OptiBiotix Health Plc (LON:OPTI – Get Free Report)’s share price was down 2.6% on Tuesday . The company traded as low as GBX 18.50 ($0.23) and last traded at GBX 18.75 ($0.23). Approximately 91,261 shares were traded during mid-day trading, a decline of 63% from the average daily volume of 248,946 shares. The stock had previously closed at GBX 19.25 ($0.24).
OptiBiotix Health Stock Performance
The company has a debt-to-equity ratio of 4.51, a current ratio of 3.59 and a quick ratio of 7.89. The company has a market capitalization of £17.10 million, a price-to-earnings ratio of -125.00 and a beta of 1.62. The stock has a 50 day simple moving average of GBX 23.06 and a two-hundred day simple moving average of GBX 25.66.
About OptiBiotix Health
OptiBiotix Health Plc, a life sciences company, engages in the discovery and development of microbiome modulators primarily in the United Kingdom. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that impacts human physiology deriving potential health benefits.
Featured Articles
- Five stocks we like better than OptiBiotix Health
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Silicon Motion Proves That AI in Motion Stays in Motion
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Undervalued UnitedHealth Group Won’t Be For Long
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- The 5 Stocks Most Sold By Insiders This Year
Receive News & Ratings for OptiBiotix Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptiBiotix Health and related companies with MarketBeat.com's FREE daily email newsletter.
